Scientists search for a way to measure hope in untreatable disease
NCT ID NCT06018519
Summary
This study aims to prepare for future treatment trials for Creatine Transporter Deficiency (CTD), a rare genetic disorder that causes severe intellectual disability, seizures, and movement problems. Researchers will test many different questionnaires, games, and activities on about 200 participants, including patients and healthy volunteers, to find which ones are most suitable for tracking changes in patients with significant cognitive challenges. The goal is to identify reliable tools that can be used to test if future experimental drugs are working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CREATINE TRANSPORTER DEFECT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Woman, mother and child hospital, Hospices Civils de Lyon
RECRUITINGBron, 69500, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.